Report on the Fifth Conference on Retroviruses and Opportunistic Infections.

Research output: Contribution to journalArticle

Abstract

Presentations made at the Fifth Conference on Retroviruses and Opportunistic Infections are summarized. Hundreds of papers confirmed and analyzed the impact of highly active antiretroviral therapy (HAART) in clinical trials and routine clinical care. Papers on HAART therapy and research on the underlying dynamics of HIV infection are highlighted in the areas of epidemiology, prevention, HIV pathophysiology, primary HIV infection, combination antiretroviral therapy, salvage therapy, antiretroviral toxicities, adherence issues, and opportunistic infections. The papers show that the theoretical and therapeutic advances made in 1996 and 1997 are tempered by challenges that remain: the emergence of viral resistance, extensive cross resistance affecting antiretrovirals still in the development pipeline, the failure to extend the benefits of antiretroviral therapy to the vast majority of AIDS patients, the continuing problem of HIV transmission, and the need and frustrating search for a vaccine.

Original languageEnglish (US)
Pages (from-to)27-29
Number of pages3
JournalAIDS clinical care
Volume10
Issue number4
StatePublished - 1998
Externally publishedYes

Fingerprint

Highly Active Antiretroviral Therapy
HIV Infections
HIV
Salvage Therapy
Opportunistic Infections
Therapeutics
Acquired Immunodeficiency Syndrome
Epidemiology
Vaccines
Clinical Trials
Research

Cite this

Report on the Fifth Conference on Retroviruses and Opportunistic Infections. / Soloway, Bruce H.

In: AIDS clinical care, Vol. 10, No. 4, 1998, p. 27-29.

Research output: Contribution to journalArticle

@article{7d445b5284234573b0197a80c6326410,
title = "Report on the Fifth Conference on Retroviruses and Opportunistic Infections.",
abstract = "Presentations made at the Fifth Conference on Retroviruses and Opportunistic Infections are summarized. Hundreds of papers confirmed and analyzed the impact of highly active antiretroviral therapy (HAART) in clinical trials and routine clinical care. Papers on HAART therapy and research on the underlying dynamics of HIV infection are highlighted in the areas of epidemiology, prevention, HIV pathophysiology, primary HIV infection, combination antiretroviral therapy, salvage therapy, antiretroviral toxicities, adherence issues, and opportunistic infections. The papers show that the theoretical and therapeutic advances made in 1996 and 1997 are tempered by challenges that remain: the emergence of viral resistance, extensive cross resistance affecting antiretrovirals still in the development pipeline, the failure to extend the benefits of antiretroviral therapy to the vast majority of AIDS patients, the continuing problem of HIV transmission, and the need and frustrating search for a vaccine.",
author = "Soloway, {Bruce H.}",
year = "1998",
language = "English (US)",
volume = "10",
pages = "27--29",
journal = "AIDS clinical care",
issn = "1043-1543",
publisher = "Massachussetts Medical Society",
number = "4",

}

TY - JOUR

T1 - Report on the Fifth Conference on Retroviruses and Opportunistic Infections.

AU - Soloway, Bruce H.

PY - 1998

Y1 - 1998

N2 - Presentations made at the Fifth Conference on Retroviruses and Opportunistic Infections are summarized. Hundreds of papers confirmed and analyzed the impact of highly active antiretroviral therapy (HAART) in clinical trials and routine clinical care. Papers on HAART therapy and research on the underlying dynamics of HIV infection are highlighted in the areas of epidemiology, prevention, HIV pathophysiology, primary HIV infection, combination antiretroviral therapy, salvage therapy, antiretroviral toxicities, adherence issues, and opportunistic infections. The papers show that the theoretical and therapeutic advances made in 1996 and 1997 are tempered by challenges that remain: the emergence of viral resistance, extensive cross resistance affecting antiretrovirals still in the development pipeline, the failure to extend the benefits of antiretroviral therapy to the vast majority of AIDS patients, the continuing problem of HIV transmission, and the need and frustrating search for a vaccine.

AB - Presentations made at the Fifth Conference on Retroviruses and Opportunistic Infections are summarized. Hundreds of papers confirmed and analyzed the impact of highly active antiretroviral therapy (HAART) in clinical trials and routine clinical care. Papers on HAART therapy and research on the underlying dynamics of HIV infection are highlighted in the areas of epidemiology, prevention, HIV pathophysiology, primary HIV infection, combination antiretroviral therapy, salvage therapy, antiretroviral toxicities, adherence issues, and opportunistic infections. The papers show that the theoretical and therapeutic advances made in 1996 and 1997 are tempered by challenges that remain: the emergence of viral resistance, extensive cross resistance affecting antiretrovirals still in the development pipeline, the failure to extend the benefits of antiretroviral therapy to the vast majority of AIDS patients, the continuing problem of HIV transmission, and the need and frustrating search for a vaccine.

UR - http://www.scopus.com/inward/record.url?scp=0032038212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032038212&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 27

EP - 29

JO - AIDS clinical care

JF - AIDS clinical care

SN - 1043-1543

IS - 4

ER -